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Abstract 
Background: MicroRNA is a type of small RNA of about 22 nucleotide length. Most popular miRNAs are found in 
the liver and are extensively important in determining the biological and clinical functions. MicroRNA, in host cells, 
may impact the replication of viruses either positively or negatively. In this study the miR-122 expression was 
examined and compared in three groups, two sample groups of patients with chronic hepatitis and hepatitis B virus-
associated cirrhosis, and a healthy control group. 
Materials and Methods: In this study, 108 samples of whole blood were taken from each participant. Then the 
miRNA expression evaluation was conducted through relative real time PCR. 
Results: The results indicated that miR-122 expression was elevated in patients with chronic hepatitis B and HBV 
related cirrhosis about 1.8 times (P<0.05) more than control group which is statistically significant.   
Conclusion: According to the results of this study, measuring the miR-122 expression levels may be used as a 
biomarker and an indicator of the disease progression of chronic hepatitis B to HBV related cirrhosis to HCC, but 
needs more investigations and more samples. 
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Hepatitis B Virus (HBV) is the most popular 
infectious disease throughout the world (1). Hepatitis 
B infection is an inflammatory and liver necrosis 
disease, and still remains an important global issue 
(2). MicroRNA is a type of small RNAs of about 22 
nucleotide length; it is expressed in most eukaryotes 
and acts as a regulating key of gene expression by 
attaching to the end of 3’mRNA target (3). Viral 
mRNA targeted by cellular mir-RNA, includes all 
cells involved in cell survival, replication and immune 
responses, through which cell cycle of viruses 
improves in a host cell environment (4). Viruses can 
affect the microRNA expression profiles positively to 
promote replication potential and pathogenesis. (5). 
The sequence of miRNA-122 includes a single 
genomic locus on chromosome 18 in humans derived 
from 85 coding exons. Reduced miR-122 expression 
in HBV patients causes enhanced replication and 
simulation of the virus, indicating Cyclin G1 
expression suppression by miR-122. (6) In this study 
the miR-122 expression was examined and compared 
in three groups, two sample groups of patients with 
chronic hepatitis and hepatitis B virus-associated 
cirrhosis, and a healthy control group. 
Methods 
In this study 108 participants (54 men and 54 
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women), including patients with chronic hepatitis B, 
HBV related cirrhosis and the control group were 
examined. The samples of whole blood (5ml) treated 
with EDTA, were taken from participants.  
The RNA extraction was done using 2ml whole 
blood by RNX-PLUS kit following the manufacturer 
guidelines.   
To evaluate the miRNA expression, relative 
real time PCR by Parsgenome, Iran mirAmp kit used. 
The Real time PCR by ΔΔCT was used to measure 
miRNA expressions. Finally, the collected data was 
processed with T-Test.  
Results 
The results of this study indicated that miRNA-
122 expression in patients with chronic hepatitis B 
and HBV related cirrhosis was 1.8 times higher than 
the control group which is statistically significant (P < 
0.05). Figure 1 shows the results of the study in all 
three groups. 
Discussion 
The target miRNAs act as a new basic key in 
controlling gene expression of cells. To predict the 
risk of disease progression in patients with chronic 
hepatitis B is of considerable importance. The reports 
state that the level of miR-122 relates to HBs antigen 
directly, which is an indicator for viral translation; 
miR-122 levels can be an important indicator for 
progressing stages of the disease (7).  
In this study, two groups of patients with 
chronic hepatitis B and HBV related cirrhosis showed 
an increase in HBsAg and miR-122 levels. The most 
popular miRNAs are found in liver and are 
extensively important in determining the biological 
and clinical functions (8). In 2010, some reports by 
TaqMan format real time PCR indicated that miR-122 
contains a suppression effect in the expressing of 
HBV genes (9).  
Jian Zhou et al, aimed to examine the effect of 
HBV related HCC on miRNAs and indicated that 
miRNA expressions in four sample groups (healthy, 
chronic hepatitis B, cirrhosis, and HBV related HCC) 
through microarray to measure the miR-122 
expression levels, which showed a significant 
increase in patients with HCC compared to the 
healthy individuals. But measuring miR-122 
expression by qRT-PCR method showed a decrease in 
HCC group compared to the healthy individuals (10).  
Our findings indicated that the rate of miR-122 
expression in patients with chronic hepatitis B and 
HBV related cirrhosis was 1.8 times more than the 
healthy control group which is statistically significant 
(P < 0.05). 
The results of this study indicated that patients 
with liver cirrhosis exhibited higher levels of miR-
122. In this investigation, we focused on limited 
miRNAs role in interactions between host and the 
virus, especially in hosts with HBV. Various studies 
revealed that miRNA plays a key role in viral 
physiologic and pathologic processes.  
Comparing the results with previous findings, 
shows conflicting results; the results of Jian Zhou et 
al. (10) reported a decrease in miR-122 expression 
levels in Hepatitis B patients, however our results 
indicates that miR-122 expression increases in 
hepatitis B patients, this difference in results can be 
described by the fact that previous investigations were 
on patients with HCC, but the sample group in this 
study only included patients with HBV related 
cirrhosis. 
This study shows that the increased miR-122 
expression compared to the control group can be used 
as a biomarker to indicate chronic hepatitis B and 
HBV related cirrhosis before progressing to 
Hepatocellular carcinoma. 
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Figure 1. The miR-122 expression levels in three groups by T- test 
method (P value = 0.047) 
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